International Symposium on Oncology, Immunotherapy and Biomarkers (ISOIB - 26)

This track will explore the latest breakthroughs in immunotherapy, focusing on novel therapeutic agents and their mechanisms of action. Discussions will include clinical trial outcomes and the integration of immunotherapy into standard cancer treatment protocols.

This session will delve into the role of biomarkers in enhancing cancer diagnosis and predicting patient outcomes. Researchers will present findings on the identification and validation of biomarkers across various cancer types.

This track will examine the principles and applications of precision medicine in oncology, emphasizing personalized treatment strategies based on genetic and molecular profiling. Case studies will illustrate the impact of tailored therapies on patient care.

This session will investigate the interactions between tumor cells and their microenvironment, highlighting how these relationships influence cancer progression and metastasis. Presentations will cover both experimental and clinical insights into tumor biology.

This track will focus on the translation of laboratory findings into clinical applications, addressing the challenges and successes of moving from bench to bedside. Participants will discuss innovative approaches to enhance the efficacy of cancer therapies.

This session will explore the impact of health policy on cancer treatment accessibility and quality of care. Experts will discuss strategies to improve healthcare delivery and address disparities in cancer treatment across populations.

This track will highlight the latest research in cancer biology, focusing on novel pathways and mechanisms that drive tumorigenesis. Presentations will cover cutting-edge studies that may lead to new therapeutic targets.

This session will examine the rationale and effectiveness of combination therapies in cancer treatment. Researchers will present data on synergistic effects of combining different modalities, including chemotherapy, immunotherapy, and targeted therapies.

This track will address the specific challenges faced in pediatric oncology, including treatment side effects and long-term outcomes. Innovative approaches and recent advancements in the treatment of childhood cancers will be discussed.

This session will focus on the design and execution of clinical trials in oncology, emphasizing best practices and regulatory considerations. Participants will share insights on improving patient recruitment and retention in cancer studies.

This track will explore emerging trends and future directions in cancer research, including novel therapeutic approaches and technologies. Experts will discuss the potential impact of artificial intelligence and big data on oncology.